Cupid Q2 Consolidated Net Profit Rises To ₹56.22 Crore As Revenue Reaches ₹188 Crore

Market snapshot: Cupid Limited reported a 133% year-on-year surge in Q2 consolidated net profit to ₹56.22 crore, up from ₹24.13 crore in the year-ago period. Consolidated revenue from operations for the quarter expanded 122% YoY to ₹187.86 crore, while EBITDA margin compressed to 29.16% from 33.65% in the corresponding prior-year period.

Data Snapshot

• Q2 consolidated net profit grew 133% YoY to ₹56.22 crore compared to ₹24.13 crore.
• Q2 consolidated revenue from operations rose 122% YoY to ₹187.86 crore from ₹84.45 crore.
• Q2 EBITDA increased 93% YoY to ₹54.77 crore compared to ₹28.41 crore in the year-ago period.
• Q2 EBITDA margin stood at 29.16%, registering a compression of 449 bps from 33.65% YoY.

What's Changed

• Consolidated net profit increased to ₹56.22 crore in Q2 against ₹24.13 crore in Q2 of the prior year.
• Quarterly revenue grew to ₹187.86 crore, more than doubling from ₹84.45 crore reported YoY.
• EBITDA margin normalized to 29.16% compared to 33.65% in the prior-year quarter due to shift in business mix.

Key Takeaways

• Strong volume scale across domestic consumer healthcare and FMCG distribution channels driven by retail footprint expansion.
• Revenue growth outpaced operating margin expansion, reflecting increased investments in brand distribution.
• Net profit line benefited from operating leverage despite a slight dip in EBITDA margins.

SAHI Perspective

Cupid continues to transition from an export-focused B2B manufacturer into a scaled consumer healthcare brand. While EBITDA margin compressed YoY by 449 basis points to 29.16%, the triple-digit topline expansion demonstrates significant operational momentum in domestic consumer distribution channels.

Market Implications

Strong revenue momentum and robust bottom-line delivery provide operational validation for ongoing retail rollouts. Investors will monitor whether margin normalization stabilizes near the 29-30% range as distribution scale matures.

Trading Signals

Market Bias: Bullish

Directionally positive on strong YoY earnings growth, with net profit expanding 133% to ₹56.22 crore and revenue doubling to ₹187.86 crore.

Overweight: Consumer Healthcare, Personal Care & FMCG

Trigger Factors:

• Execution of retail expansion partnerships
• Commissioning of Palava manufacturing facility
• Margin stability across upcoming quarters

Time Horizon: Near-term (0-3 months)

Industry Context

The Indian personal care and consumer healthcare market is undergoing structural growth, with companies building direct retail distribution networks benefiting from higher volume scale and brand visibility.

Key Risks to Watch

• Potential input cost inflation impacting operating margins
• Execution timelines on capacity expansion projects
• Reversion in demand trends across international export markets

Recent Developments

Cupid announced a long-term retail partnership with V2 Retail Limited across 425+ stores to expand its dedicated consumer space.

Closing Insight

Cupid's robust Q2 performance highlights operational strength as revenue scale compensates for short-term margin compression.

High Performance Trading with SAHI.